Inhibitor Therapeutics, Inc. (INTI) Return on equity 2016–2018
Inhibitor Therapeutics, Inc. (INTI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-14065.2%FY2018 · since FY2016: -99.6% → -14065.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | -14065.2% | -11002.6 pp |
| FY2017 | -3062.6% | -2963.0 pp |
| FY2016 | -99.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice